- Home
- CDNA vs MFA Comparison
CDNA vs MFA Comparison
Compare CDNA & MFA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDNA
- MFA
- Stock Information
- Founded
- CDNA 1998
- MFA 1997
- Country
- CDNA United States
- MFA United States
- Employees
- CDNA N/A
- MFA 348
- Industry
- CDNA Medical Specialities
- MFA Real Estate Investment Trusts
- Sector
- CDNA Health Care
- MFA Real Estate
- Exchange
- CDNA Nasdaq
- MFA Nasdaq
- Market Cap
- CDNA 1.0B
- MFA 980.3M
- IPO Year
- CDNA 2014
- MFA N/A
- Fundamental
- Price
- CDNA $18.85
- MFA $9.52
- Analyst Decision
- CDNA Buy
- MFA Buy
- Analyst Count
- CDNA 6
- MFA 6
- Target Price
- CDNA $30.33
- MFA $12.50
- AVG Volume (30 Days)
- CDNA 959.0K
- MFA 1.3M
- Earning Date
- CDNA 07-30-2025
- MFA 08-07-2025
- Dividend Yield
- CDNA N/A
- MFA 15.13%
- EPS Growth
- CDNA N/A
- MFA N/A
- EPS
- CDNA 1.07
- MFA 0.99
- Revenue
- CDNA $346,421,000.00
- MFA $292,245,000.00
- Revenue This Year
- CDNA $13.31
- MFA N/A
- Revenue Next Year
- CDNA $15.46
- MFA $14.73
- P/E Ratio
- CDNA $17.58
- MFA $9.61
- Revenue Growth
- CDNA 25.92
- MFA 52.95
- 52 Week Low
- CDNA $14.09
- MFA $7.85
- 52 Week High
- CDNA $34.84
- MFA $13.45
- Technical
- Relative Strength Index (RSI)
- CDNA 51.86
- MFA 45.38
- Support Level
- CDNA $18.64
- MFA $9.26
- Resistance Level
- CDNA $19.84
- MFA $9.73
- Average True Range (ATR)
- CDNA 0.80
- MFA 0.18
- MACD
- CDNA -0.07
- MFA -0.00
- Stochastic Oscillator
- CDNA 25.60
- MFA 30.00
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
About MFA MFA Financial Inc.
MFA Financial Inc is a specialty finance company that invests in and finances residential mortgage assets. Its principal business objective is to deliver shareholder value through the generation of distributable income and through asset performance linked to residential mortgage credit fundamentals. The company selectively invests in residential mortgage assets with a focus on credit analysis, projected prepayment rates, interest rate sensitivity and expected return. The company's reportable segments include mortgage-related assets and Lima One.